Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma

Clinical trial NCT05809869 · UNKNOWN

Trial details

NCT number: NCT05809869
Sponsor: The University of Hong Kong
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2023-02-15
Primary completion: 2025-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.